Cargando…
High Resolution Melt analysis for mutation screening in PKD1 and PKD2
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder. It is characterized by focal development and progressive enlargement of renal cysts leading to end-stage renal disease. PKD1 and PKD2 have been implicated in ADPKD pathogenesis but genetic...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206831/ https://www.ncbi.nlm.nih.gov/pubmed/22008521 http://dx.doi.org/10.1186/1471-2369-12-57 |
_version_ | 1782215490616164352 |
---|---|
author | Bataille, Stanislas Berland, Yvon Fontes, Michel Burtey, Stéphane |
author_facet | Bataille, Stanislas Berland, Yvon Fontes, Michel Burtey, Stéphane |
author_sort | Bataille, Stanislas |
collection | PubMed |
description | BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder. It is characterized by focal development and progressive enlargement of renal cysts leading to end-stage renal disease. PKD1 and PKD2 have been implicated in ADPKD pathogenesis but genetic features and the size of PKD1 make genetic diagnosis tedious. METHODS: We aim to prove that high resolution melt analysis (HRM), a recent technique in molecular biology, can facilitate molecular diagnosis of ADPKD. We screened for mutations in PKD1 and PKD2 with HRM in 37 unrelated patients with ADPKD. RESULTS: We identified 440 sequence variants in the 37 patients. One hundred and thirty eight were different. We found 28 pathogenic mutations (25 in PKD1 and 3 in PKD2 ) within 28 different patients, which is a diagnosis rate of 75% consistent with literature mean direct sequencing diagnosis rate. We describe 52 new sequence variants in PKD1 and two in PKD2. CONCLUSION: HRM analysis is a sensitive and specific method for molecular diagnosis of ADPKD. HRM analysis is also costless and time sparing. Thus, this method is efficient and might be used for mutation pre-screening in ADPKD genes. |
format | Online Article Text |
id | pubmed-3206831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32068312011-11-03 High Resolution Melt analysis for mutation screening in PKD1 and PKD2 Bataille, Stanislas Berland, Yvon Fontes, Michel Burtey, Stéphane BMC Nephrol Research Article BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder. It is characterized by focal development and progressive enlargement of renal cysts leading to end-stage renal disease. PKD1 and PKD2 have been implicated in ADPKD pathogenesis but genetic features and the size of PKD1 make genetic diagnosis tedious. METHODS: We aim to prove that high resolution melt analysis (HRM), a recent technique in molecular biology, can facilitate molecular diagnosis of ADPKD. We screened for mutations in PKD1 and PKD2 with HRM in 37 unrelated patients with ADPKD. RESULTS: We identified 440 sequence variants in the 37 patients. One hundred and thirty eight were different. We found 28 pathogenic mutations (25 in PKD1 and 3 in PKD2 ) within 28 different patients, which is a diagnosis rate of 75% consistent with literature mean direct sequencing diagnosis rate. We describe 52 new sequence variants in PKD1 and two in PKD2. CONCLUSION: HRM analysis is a sensitive and specific method for molecular diagnosis of ADPKD. HRM analysis is also costless and time sparing. Thus, this method is efficient and might be used for mutation pre-screening in ADPKD genes. BioMed Central 2011-10-18 /pmc/articles/PMC3206831/ /pubmed/22008521 http://dx.doi.org/10.1186/1471-2369-12-57 Text en Copyright ©2011 Bataille et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bataille, Stanislas Berland, Yvon Fontes, Michel Burtey, Stéphane High Resolution Melt analysis for mutation screening in PKD1 and PKD2 |
title | High Resolution Melt analysis for mutation screening in PKD1 and PKD2 |
title_full | High Resolution Melt analysis for mutation screening in PKD1 and PKD2 |
title_fullStr | High Resolution Melt analysis for mutation screening in PKD1 and PKD2 |
title_full_unstemmed | High Resolution Melt analysis for mutation screening in PKD1 and PKD2 |
title_short | High Resolution Melt analysis for mutation screening in PKD1 and PKD2 |
title_sort | high resolution melt analysis for mutation screening in pkd1 and pkd2 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206831/ https://www.ncbi.nlm.nih.gov/pubmed/22008521 http://dx.doi.org/10.1186/1471-2369-12-57 |
work_keys_str_mv | AT bataillestanislas highresolutionmeltanalysisformutationscreeninginpkd1andpkd2 AT berlandyvon highresolutionmeltanalysisformutationscreeninginpkd1andpkd2 AT fontesmichel highresolutionmeltanalysisformutationscreeninginpkd1andpkd2 AT burteystephane highresolutionmeltanalysisformutationscreeninginpkd1andpkd2 |